Jun 22, 2009
Lilly Declares Third-Quarter Dividend

Jun 15, 2009
Eli Lilly and Company Announces New Drug Discovery Initiative

Jun 10, 2009
FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications

Jun 8, 2009
Successful Disease Management Programs Can Play Role in Health Care Reform

Jun 7, 2009
Exenatide Once Weekly Provided Sustained Improvements in Glycaemic Control with Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

Jun 6, 2009
Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes

Jun 5, 2009
Bart Peterson to Join Lilly Leadership Team

Jun 3, 2009
Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration

Jun 2, 2009
R. David Hoover Elected to Lilly Board of Directors

May 31, 2009
Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients

May 29, 2009
ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer

May 21, 2009
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial

May 21, 2009
Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials

May 19, 2009
Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management

May 18, 2009
Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting

May 18, 2009
Lilly to Celebrate Second Annual Global Day of Service May 20

May 15, 2009
Eleventh Annual Welcome Back Awards Program Honors Individuals who Positively Impact the Depression Community

May 14, 2009
Lilly Chairman & CEO Lechleiter Says Innovation Is Vital-But-Missing Plank in Health Reform Debate

May 12, 2009
Lilly Set to Unveil More Than 50 Studies at ASCO 2009

May 11, 2009
Groundbreaking Diabetes Disease Management Program Honored With URAC National Best Practices Award

May 6, 2009
Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples

May 5, 2009
Lilly USA, LLC and Vision Racing Encourage Fans to get on Track With Their Health

May 5, 2009
New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel

Apr 22, 2009
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene

Apr 20, 2009
Lilly Declares Second-Quarter Dividend

Apr 20, 2009
Lilly Reports Strong First-Quarter 2009 Results

Apr 17, 2009
Lilly Names Susan Mahony Senior Vice President of Human Resources

Apr 8, 2009
Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density

Apr 8, 2009
J. Michael Cook to Retire from Lilly Board of Directors

Apr 6, 2009
Lilly Sets Date and Conference Call for First-Quarter 2009 Financial Results Announcement

Apr 3, 2009
U.S. Appeals Court Issues Ruling in Support of Lilly in Ariad Patent Litigation

Mar 29, 2009
Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research

Mar 27, 2009
Anthem Blue Cross and Blue Shield, Eli Lilly and Company Establish Coalition to Help Improve the Health of Indiana Residents with Diabetes

Mar 23, 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression

Mar 23, 2009
Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis

Mar 17, 2009
Pathway for Biosimilars Act Protects Patients, Promotes Competition, Preserves Innovation and Creates Quality Jobs, Lilly Says

Mar 9, 2009
Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene

Mar 4, 2009
Lilly's Anthony Murphy Announces Retirement

Mar 2, 2009
Lilly Announces Leadership Changes

Feb 23, 2009
Grammy-nominated Singer Angie Stone Encourages African-Americans in Birmingham to Fearlessly FACE Diabetes

Feb 23, 2009
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI

Feb 18, 2009
Ralph Alvarez Elected to Lilly Board of Directors

Feb 3, 2009
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee

Jan 30, 2009
Lilly Announces Senior Leadership Change

Jan 30, 2009
Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study

Jan 29, 2009
Lilly Reports Fourth-Quarter and Full-Year 2008 Results

Jan 16, 2009
Lilly to Sponsor Martin Luther King Day 'I AM CHANGE' Campaign as Part of Inaugural Gift to President-Elect Obama

Jan 15, 2009
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices

Jan 12, 2009
Lilly Files Form 8-K/A Detailing Pro Forma Impact of ImClone Acquisition

Jan 7, 2009
FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults

Jan 7, 2009
Lilly Sets Date and Conference Call for Fourth-Quarter and Full-Year 2008 Financial Results Announcement

Dec 31, 2008
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel

Dec 18, 2008
Lilly Foundation Provides $50,000 Donation to Gleaners Food Bank

Dec 18, 2008
Prasugrel Receives Positive Opinion from the European Committee for Medicinal Products for Human Use (CHMP)

Dec 15, 2008
Lilly Announces Dividend Increase

Dec 12, 2008
Lilly Chairman Taurel Says Promise of Personalized Medicine Could be Jeopardized by Short-Sighted Public Policies

Dec 11, 2008
Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance

Dec 11, 2008
Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback

Dec 10, 2008
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)

Dec 8, 2008
Lilly Global Day of Service Receives National and Local Recognition

Nov 28, 2008
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain

Nov 24, 2008
Lilly Completes Acquisition of ImClone Systems

Nov 24, 2008
Lilly Receives NCQA Health Information Product Certification for Interactive Online Health Education Answers Program

Nov 21, 2008
Lilly Completes Cash Tender Offer for ImClone Systems

Nov 19, 2008
Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Business Civic Leadership Center

Nov 18, 2008
Lilly Diabetes, International Diabetes Federation and International Society of Pediatric and Adolescent Diabetes Announce the 2nd Annual Inspired by Diabetes Creative Expression Competition

Nov 17, 2008
Lilly Licenses U.S. Rights for Tadalafil PAH Indication to United Therapeutics

Nov 13, 2008
Lilly Contributes $11.1 Million to United Way Annual Campaign

Nov 12, 2008
Lilly Diabetes Partners with the International Diabetes Federation and Healthy Interactions to Launch Conversation Map(TM) Tools in Latin America

Nov 12, 2008
Lilly Announces Major Donation of Insulin to International Diabetes Federation's Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa

Nov 12, 2008
Deadline Extended to Submit Nominations for Depression Awards Program

Nov 9, 2008
Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death

Oct 30, 2008
American Diabetes Association and Eli Lilly and Company Unite to Educate and Empower African-Americans with Diabetes

Oct 28, 2008
Teach For America and Lilly Launch Program to Match Lilly Employees with Teachers in Underserved Public Schools

Oct 27, 2008
From Pain to Unexpected Fame: One Woman's Journey to Know Fibro

Oct 27, 2008
Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States

Oct 24, 2008
European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia

Oct 23, 2008
Winning Entry from Oncology On Canvas(SM) Art Competition Depicts Survivorship Despite Breast Cancer; Wholeness Despite Mastectomy

Oct 23, 2008
Lilly Reports Third-Quarter Results

Oct 20, 2008
Lilly Declares Fourth-Quarter Dividend

Oct 20, 2008
Douglas Oberhelman Elected to Lilly Board of Directors

Oct 16, 2008
Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application

Oct 15, 2008
Lilly Launches New FORTEO Delivery Device

Oct 14, 2008
Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share

Oct 10, 2008
Healthcare Resources Available in Difficult Times

Oct 10, 2008
Lilly Recognized as One of the World's Top Biopharmaceutical Employers

Oct 7, 2008
Lilly Sets Date and Conference Call for Third Quarter 2008 Financial Results Announcement

Oct 7, 2008
Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline

Oct 7, 2008
Eli Lilly and Company Resolves Investigation Involving Numerous States

Oct 6, 2008
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

Oct 3, 2008
Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement

Oct 1, 2008
Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound

Sep 29, 2008
FDA Grants Lilly's ALIMTA(R) (Pemetrexed for Injection) Third U.S. Approval

Sep 26, 2008
FDA Continues to Review Prasugrel New Drug Application

Sep 26, 2008
CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe

Sep 24, 2008
Lilly to Sponsor Congressional Black Caucus Foundation's Annual Legislative Conference

Sep 24, 2008
Lilly Set to Become First Pharmaceutical Research Company to Disclose Physician Payments

Sep 18, 2008
John Lechleiter Named Chairman of Lilly's Board of Directors

Sep 9, 2008
First Reported Head-to-Head Study Showed BYETTA(R) (exenatide) Injection Provided Greater Reduction in Post-Meal Glucose Levels Than Januvia(TM) (sitagliptin) in Patients With Type 2 Diabetes

Sep 3, 2008
Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel

Sep 3, 2008
New Crossover Study Shows Prasugrel Significantly Reduced Platelet Aggregation in Patients with Acute Coronary Syndromes Compared with Clopidogrel at High Doses

Sep 2, 2008
Elanco Announces Location for New Global Headquarters in Hancock County

Sep 2, 2008
Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months

Sep 2, 2008
Survey Highlights How Family Support and Finding and Staying on the Right Treatment Can Make a Difference in Keeping Patients with Serious Mental Illness Well

Aug 31, 2008
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel

Aug 25, 2008
Lilly and Amylin Set Date and Time for Conference Call

Aug 25, 2008
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study

Aug 22, 2008
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder

Aug 21, 2008
Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events

Aug 20, 2008
Lilly Announces Completion of SGX Acquisition

Aug 20, 2008
Elanco Announces Acquisition of Posilac(R) Dairy Business

Aug 6, 2008
Lilly Sells its Greenfield, Indiana, Operations to Covance; Expands Existing Collaboration Between the Two Companies

Aug 4, 2008
Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals

Jul 30, 2008
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease

Jul 24, 2008
Eli Lilly and Company and Vision Racing Sponsor Vision Wellness Tour at the IndyCar Series Across the Country

Jul 24, 2008
Lilly Reports Solid Second-Quarter Results

Jul 16, 2008
The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds

Jul 13, 2008
Lilly Partners With the National Council of La Raza to Fight Chronic Disease

Jul 10, 2008
Lilly Supports Industry Code on Interactions with Healthcare Professionals

Jul 8, 2008
Lilly to Acquire SGX Pharmaceuticals

Jun 27, 2008
Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Campaign

Jun 27, 2008
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder

Jun 25, 2008
Lilly Sets Date and Conference Call for Second Quarter 2008 Financial Results Announcement

Jun 23, 2008
FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel

Jun 23, 2008
Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference

Jun 16, 2008
FDA Approves Cymbalta(R) for the Management of Fibromyalgia

Jun 13, 2008
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study

Jun 12, 2008
Lilly and TransPharma Medical Announce Licensing and Development Agreement

Jun 10, 2008
Lilly's Connelly Appointed to the President's Commission on White House Fellowships

Jun 9, 2008
After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008

Jun 9, 2008
Lilly to Provide Aid to Indiana Tornado and Flood Victims

Jun 9, 2008
When Words Fail ... Cancer Art Competition Gives Rise to Expression and Hope

Jun 7, 2008
Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss

Jun 7, 2008
Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight

Jun 5, 2008
Inspired by Diabetes U.S. National Contest Winners Share Stories of Perseverance and Success in Managing Diabetes

May 29, 2008
Art Exhibit Honors National Cancer Survivors Day

May 29, 2008
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration

May 28, 2008
Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer

May 21, 2008
Lilly Announces Changes in Key Leadership Roles

May 20, 2008
Lilly to Provide More Than $1 Million in Disaster Aid

May 19, 2008
American Psychiatric Foundation, Lilly Foundation and Give an Hour Join Forces to Provide Mental Health Care to Iraq and Afghanistan Veterans

May 15, 2008
ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)

May 15, 2008
Lilly Employees from Nearly 50 Nations Participate in Company's First-Ever Global Day of Service

May 15, 2008
Lilly Employees from Nearly 50 Nations Participate in Company's First-Ever Global Day of Service

May 14, 2008
Lilly Employees from Nearly 50 Nations Participate in Company's First-Ever Global Day of Service

May 13, 2008
Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians

May 13, 2008
More Than 8,400 Lilly Employees to Participate in Massive One-Day City Makeover May 15

May 12, 2008
Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex

May 8, 2008
FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents

May 2, 2008
2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression

May 1, 2008
Lilly Oncology to Unveil More Than 50 Studies at ASCO 2008

Apr 30, 2008
Lilly CEO Praises Massachusetts' Leadership in Biotech, Urges Policy Prescriptions to Help Ensure State's Investment Generates Dividends and Jobs

Apr 30, 2008
Lilly CEO Urges Policy Prescriptions to Help Ensure Public and Private Biotech Investments Generate Dividends and U.S. Job Growth

Apr 21, 2008
Lilly Declares Second-Quarter Dividend

Apr 21, 2008
Lilly Reports Solid First-Quarter Results

Apr 16, 2008
Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards

Apr 16, 2008
Lilly to Streamline Indianapolis Manufacturing and Engineering Operations

Apr 15, 2008
Neo-Soul Singer Angie Stone Belts a New Tune: Be Fearless in the FACE of Diabetes

Apr 4, 2008
FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis

Apr 2, 2008
Lilly Adjusts Time of Conference Call for First Quarter 2008 Financial Results Announcement

Mar 31, 2008
Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease

Mar 29, 2008
Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel

Mar 26, 2008
Lilly Sets Date and Conference Call for First Quarter 2008 Financial Results Announcement

Mar 14, 2008
Statement from Eli Lilly and Company: Response to Today's New York Times Article, 'Lilly E-Mail Discussed Off-Label Drug Use'

Mar 13, 2008
Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement

Mar 12, 2008
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release

Mar 12, 2008
Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion

Mar 11, 2008
Lilly Offers Helping Hand in Fight Against Chronic Disease

Mar 7, 2008
Lilly Announces Termination of AIR Insulin Program

Mar 5, 2008
Mental Health Parity Laudable, But House Legislation Would Put Medicaid Patients at Risk, Lilly Says

Feb 28, 2008
FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment

Feb 26, 2008
Lilly and Partners In Health, Brigham and Women's Hospital Team Up to Fight MDR-TB in Former Soviet Republics

Feb 21, 2008
FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel

Feb 19, 2008
Michael L. Eskew Elected to Lilly Board of Directors

Feb 6, 2008
FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment

Jan 29, 2008
Lilly Caps Successful Year with Strong Fourth-Quarter Results

Jan 18, 2008
In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:

Jan 8, 2008
FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction

Jan 4, 2008
Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results Announcement

Jan 4, 2008
Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration

Dec 18, 2007
Sidney Taurel to Retire as Lilly CEO; John Lechleiter Named as Successor

Dec 17, 2007
Lilly and BioMS Medical Announce Global Licensing and Development Agreement

Dec 17, 2007
Lilly Announces Dividend Increase

Dec 14, 2007
Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar

Dec 6, 2007
Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy

Dec 5, 2007
Lilly Announces New President of Animal Health Division

Dec 5, 2007
Lilly Announces Pat James to Assume New Role

Nov 30, 2007
FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder

Nov 29, 2007
International Federation-Lilly Agreement Will Allow Significant Increase in MDR-TB Programmes

Nov 15, 2007
When Words Fail ... Cancer Patients Unite to Express Their Journeys on Canvas

Nov 15, 2007
Eli Lilly and Company to Receive Honor from National Urban League

Nov 14, 2007
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis

Nov 13, 2007
Deadline Extended to Submit Nominations for 10th Anniversary of Depression Awards Program

Nov 9, 2007
The Lilly MDR-TB Partnership Provides Unique Model for Fight Against Multidrug-Resistant Tuberculosis in South Africa

Nov 6, 2007
Lilly Contributes $10.8 Million to United Way Annual Campaign

Nov 6, 2007
NBC 'Today' Co-Host Al Roker to Serve as a National Ambassador for Inspired by Diabetes Campaign to Help Children With Diabetes

Nov 6, 2007
Lilly Receives NCQA Design Certification for Depression Care Management Program

Oct 31, 2007
2007 Luminous Award Winners Highlight Ovarian Cancer Treatment and the Importance of Early Detection

Oct 30, 2007
Lilly Sets Date and Time for American Heart Association Conference Call

Oct 30, 2007
Lilly and Glenmark Pharmaceuticals Announce License Agreement

Oct 29, 2007
Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients

Oct 26, 2007
Eli Lilly and Company Aids California Recovery Effort

Oct 24, 2007
Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies

Oct 18, 2007
Lilly Delivers Strong Third-Quarter Results

Oct 18, 2007
Lilly and MacroGenics Announce Licensing and Collaboration Agreement

Oct 5, 2007
Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels

Oct 2, 2007
Lilly's CEO Calls for Reform of Nation's Drug Safety System

Sep 25, 2007
Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes

Sep 25, 2007
Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes

Sep 20, 2007
Lilly Sets Date and Conference Call for Third Quarter 2007 Financial Results Announcement

Sep 20, 2007
Baseline Data From European Observational Study Highlights Characteristics of Patients with Type 2 Diabetes Initiating Insulin

Sep 18, 2007
Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division

Sep 18, 2007
The Welcome Back Awards Now Accepting Nominations to Honor Courageous Individuals Dedicated to the Depression Community

Sep 18, 2007
European Study Outlines Struggle to Control Diabetes, Significant Economic Implications to Healthcare Systems

Sep 7, 2007
Statement of Eli Lilly and Company on Dr. David Egilman Settlement:

Sep 4, 2007
Data Affirm Benefit of ALIMTA (R) (pemetrexed for injection) for Patients With Malignant Pleural Mesothelioma

Sep 3, 2007
Data Affirm Benefit of ALIMTA(R) (pemetrexed for injection) for Patients with Non-Small Cell Lung Cancer

Sep 2, 2007
Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds

Aug 21, 2007
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression

Jul 24, 2007
FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk for Invasive Breast Cancer in Two Populations of Postmenopausal Women

Jul 24, 2007
Lilly Reports Strong Second-Quarter Results; Raises Full-Year Sales and EPS Guidance

Jul 11, 2007
European Commission Approves FORSTEO(R) (teriparatide [rDNA origin] injection) for the Treatment of Osteoporosis in Men

Jul 10, 2007
Breast Cancer Survivor Jaclyn Smith Urges Women to Know Their Breast Cancer Risk Factors

Jul 4, 2007
Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics

Jun 29, 2007
Lilly Sets Date and Conference Call for Second Quarter 2007 Financial Results Announcement

Jun 21, 2007
Lilly Declares Third-Quarter Dividend

Jun 21, 2007
Lilly, International Diabetes Federation and American Diabetes Association Announce U.S. Launch of 'Inspired by Diabetes' Creative Expression Competition

Jun 20, 2007
Academy of Family Physicians Foundation Will Launch New Model of Peer Support to Drive Behavior Changes in People with Diabetes

Jun 20, 2007
Chicago Community Leaders Come Together to Confront the Diabetes Epidemic

Jun 13, 2007
Lilly Unveils Ambitious Partnership for Tuberculosis Drug Discovery

Jun 13, 2007
Lilly Tuberculosis Partnership Honored By Global Business Coalition

Jun 13, 2007
Dale M. Edgar, Ph.D., to Join Lilly; Will Head Lilly Research Lab's Discovery Sleep Research Efforts

Jun 7, 2007
Eli Lilly and Company Comments on Recent Court Rulings Regarding Zyprexa(R) Patents

Jun 6, 2007
Lilly Partners With the Make-A-Wish Foundation(R) of Greater Ohio, Kentucky & Indiana, Indiana Region to Grant Four Local Wishes

Jun 5, 2007
National Campaign Showcases the Importance of Joining Forces With 'Man's Best Friend' in Overcoming Depression

Jun 2, 2007
Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer

Jun 2, 2007
Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer

Jun 2, 2007
Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer

Jun 1, 2007
Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment

Jun 1, 2007
Lilly Announces a Call for Articles Into 2007 Luminous Award

May 25, 2007
Lilly Announces Senior Leadership Change in Manufacturing

May 23, 2007
In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, In Reducing Painful Symptoms in SSRI Non- or Partial-responders with Depression

May 23, 2007
Workplace Burden of Depression Magnified by Co-morbid Fatigue and Anxiety, New Study Shows

May 23, 2007
Study Suggests Strattera(R) Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse

May 23, 2007
Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007

May 21, 2007
Data Suggest Cymbalta(R) Improved Functioning in Patients with Generalized Anxiety Disorder

May 9, 2007
Lilly Announces New Employee Policy

May 4, 2007
Lilly Announces Senior Leadership Changes

May 3, 2007
Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain

May 1, 2007
Lilly to Publish Information on Grants and Contributions

Apr 20, 2007
In The Top 10 Most Romantic Cities, Spring is Here and Boomer Couples are Ready!

Apr 19, 2007
New Survey Shows Most Physicians Believe Diabetes Patients Are Not Receiving Appropriate Care For Diabetic Nerve Pain

Apr 16, 2007
Lilly Declares Second-Quarter Dividend

Apr 16, 2007
Lilly and the AACR Work Together To Recognize Breakthrough Research in the Fight Against Cancer

Apr 16, 2007
Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales and EPS Guidance

Apr 15, 2007
Lilly Oncology Focused on Pharmacogenomics at AACR Annual Meeting

Apr 3, 2007
Lilly Announces Completion of Hypnion Acquisition

Apr 3, 2007
New Data Show Early Non-Response to Antipsychotic Treatment May Be Strong Predictor of Subsequent Non-Response for People with Schizophrenia

Mar 29, 2007
Lilly Sets Date and Conference Call for First Quarter 2007 Financial Results Announcement

Mar 26, 2007
Enzastaurin Granted Orphan Drug Status for Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)

Mar 22, 2007
Lilly Announces Additional $50 Million Investment in Global Tuberculosis Partnership

Mar 14, 2007
Eli Lilly and Company CEO Says Biomedical Breakthroughs Are Transforming Medicine and Promise to Radically Ease the Impact of Aging

Mar 9, 2007
Lilly Oncology on Canvas(SM) Kicks Off 2007 World Tour With Month-Long Exhibition in Indianapolis

Mar 5, 2007
Lilly Announces Acquisition of Hypnion

Feb 26, 2007
Lilly Plans New Clinical Trial of Xigris(R)

Feb 14, 2007
Eli Lilly and Company Statement: Judge Grants Lilly's Request for a Permanent Injunction Involving Misleading Selection of Illegally Leaked Lilly Documents

Feb 12, 2007
Scholarship Recognizes Adults With Attention-Deficit/Hyperactivity Disorder Striving for Academic Excellence

Feb 12, 2007
PQIP Improves Medicaid Quality Of Care For Individuals With Mental Illness

Jan 31, 2007
Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and Reported EPS of $2.45

Jan 29, 2007
Lilly Announces Completion of ICOS Corporation Acquisition

Jan 16, 2007
Enrollment Completed in Pivotal Phase III Study Comparing Prasugrel to Clopidogrel in Patients With Acute Coronary Syndrome

Jan 11, 2007
Lilly Announces Strategic Changes to its Global Manufacturing Operations

Jan 5, 2007
Lilly and OSI Pharmaceuticals Announce Licensing Agreement

Jan 4, 2007
Eli Lilly and Company Statement Regarding Today's New York Times Article - January 4, 2007

Jan 4, 2007
Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2006 Financial Results Announcement

Jan 4, 2007
Lilly and Plaintiffs' Attorneys Enter Into Agreements to Settle Zyprexa(R) Product Liability Litigation

Dec 21, 2006
Eli Lilly and Company Statement Regarding Today's New York Times Article - December 21, 2006

Dec 21, 2006
Data Monitoring Committee Recommends Closing Enrollment in Recurrent Glioblastoma Study

Dec 18, 2006
Lilly Announces Dividend Increase

Dec 18, 2006
Statement from Eli Lilly and Company: Response to The New York Times Article from December 18, 2006

Dec 7, 2006
Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of Invasive Breast Cancer Risk in Postmenopausal Women

Dec 7, 2006
Lilly Delivers Promising Update to Wall Street on Strategic Priorities, Pipeline Progress and Earnings Guidance

Dec 6, 2006
'This is Not a Dress Rehearsal' Captures Cancer Patient's Spirit and Wins Lilly Oncology on Canvas(SM) Art Competition

Nov 21, 2006
BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission

Nov 20, 2006
Deadline Extended to Submit Nominations for Depression Awards Program

Nov 13, 2006
Eli Lilly and Company Foundation To Fund World-Class Diabetes Treatment and Care Program at Riley Hospital for Children

Nov 13, 2006
Ruboxistaurin Reduced Vision Loss in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy in a New Study

Nov 3, 2006
'Hair Again' Gives Cancer Journey Meaning

Oct 27, 2006
Study Suggests Strattera(R) was Effective in Treating ADHD in Children and Adolescents with ADHD and Reading Disorders

Oct 23, 2006
New Study Shows Prasugrel Achieves Faster Onset and Higher Levels of Platelet Inhibition than Clopidogrel at Approved or Higher Doses

Oct 23, 2006
Lilly Expands Biotech Capabilities to Match Expanding Biotech Pipeline

Oct 20, 2006
Lilly Launches Phase III 'GALES' Trial of ALIMTA(R) (Pemetrexed for Injection) in Small Cell Lung Cancer

Oct 19, 2006
Lilly ICOS LLC Reports Record Sales for Third Quarter of 2006

Oct 19, 2006
Lilly Reports 7% Sales Growth, 10% Earnings Growth and $.80 EPS for Third Quarter

Oct 18, 2006
In Response to a Letter to the Editor That Appears in the Oct. 19, 2006, Issue of the New England Journal of Medicine, Eli Lilly and Company Provides the Following Statement:

Oct 17, 2006
Lilly Announces Acquisition of ICOS Corporation

Oct 16, 2006
Lilly Declares Fourth-Quarter Dividend

Oct 10, 2006
Eli Lilly and Company Announces 2006 Lilly Reintegration Awards Recipients

Sep 29, 2006
Lilly Announces FDA Requirement of Additional Clinical Trial Before Ruboxistaurin Could Be Approved for Treatment of Diabetic Retinopathy

Sep 28, 2006
2006 Lilly Oncology on Canvas(SM) International Art Competition Receives More Than 2,000 Entries

Sep 27, 2006
Lilly Seeks Entries for the Second Annual Adult ADHD Focus on Your Possibilities Scholarships

Sep 26, 2006
Government Approves Lilly's Medicare Part D Patient Assistance Program

Sep 25, 2006
Lilly Sets Date and Conference Call for Third Quarter 2006 Financial Results Announcement

Sep 21, 2006
Exenatide Receives Positive Opinion From the European Committee for Medicinal Products for Human Use for the Treatment of Type 2 Diabetes

Sep 16, 2006
New Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Insulin Glargine

Sep 14, 2006
Lilly Celebrates 10 Years of Better Mealtime Blood Sugar Control with Humalog(TM)

Sep 14, 2006
Lilly Receives NCQA Program Design Certification for Several Disease Management Programs

Sep 14, 2006
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart

Sep 14, 2006
Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes

Sep 12, 2006
Awards Program Seeks to Honor Five Innovators in the Depression Community

Sep 12, 2006
Lilly Announces LillyforLife(TM) Achievement Award Winners

Sep 11, 2006
Oncology Researchers Recognized as Heroes of Chemistry

Sep 8, 2006
Eli Lilly and Company CEO Says Biomedical Breakthroughs Are Transforming Medicine and Promise to Radically Ease the Impact of Aging

Aug 31, 2006
Lilly's Taurel Calls for Japan-U.S. Economic Integration Agreement

Aug 18, 2006
Eli Lilly and Company Announces Approvable Letter Issued by FDA for Arxxant(TM) (ruboxistaurin mesylate)

Jul 28, 2006
Mental Health Prescription Program Announces Extension Through 2006

Jul 25, 2006
Older Does Not Always Mean Wiser: Survey Finds Postmenopausal Women Less Concerned About Breast Cancer Than Younger Women

Jul 21, 2006
Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006

Jul 21, 2006
Lilly Reports Second-Quarter EPS of $.76

Jul 21, 2006
Lilly and Alcon Sign Marketing Collaboration for Potentially the First Oral Medication for Diabetic Retinopathy

Jul 17, 2006
FDA Approves Lilly's Gemzar(R) For Ovarian Cancer Treatment

Jun 26, 2006
Lilly Declares Third-Quarter Dividend

Jun 22, 2006
Lilly Sets Date and Conference Call for Second Quarter 2006 Financial Results Announcement

Jun 22, 2006
Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction

Jun 11, 2006
Investigational Treatment Ruboxistaurin Demonstrated Promise in Reducing the Occurrence of Vision Loss Caused by Diabetic Retinopathy

Jun 10, 2006
BYETTA(R) Shown to Reduce Blood Glucose Levels When Added to Patients Using a TZD

Jun 10, 2006
Data on AIR(R) Inhaled Insulin System Presented at American Diabetes Association Meeting

Jun 10, 2006
BYETTA(R) Extension Study Shows Sustained Improvements in Blood Glucose Control and Progressive Weight Loss After Two Years

Jun 10, 2006
New Study Illustrates Economic Benefit of Weight Loss in People with Type 2 Diabetes

Jun 10, 2006
Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes

Jun 4, 2006
Lilly Announces Phase II Results for ALIMTA(R) in First-Line Metastatic Breast Cancer Trial

Jun 4, 2006
New Data Show Enzastaurin's Activity Across Multiple Cancer Cell Lines

Jun 4, 2006
Updated Analysis in Second-Line Treatment of Lung Cancer Trial Confirms Similar Survival for Alimta(R) and Docetaxel

Jun 3, 2006
Lilly Breast Cancer Studies Explore Potential Role of Pharmacogenomics in Customizing Chemotherapy

Jun 2, 2006
Lilly Launches New Award To Promote Enlightened Oncology Reporting

May 31, 2006
Lilly Launches Phase III Trial of Once-Daily, Targeted Oral Cancer Agent

May 24, 2006
Study Suggests Atomoxetine Significantly Improved Functioning in Children with Both ADHD and Anxiety Disorders

May 23, 2006
New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression

May 23, 2006
Lilly Oncology Prepares for Strong Showing at ASCO 2006; Targets Breast Cancer and Other Tumors with 79 Studies

May 22, 2006
New Data Presented on the Effect of Cymbalta(R) on Sexual Function in Depressed Patients

May 22, 2006
First Head-to-Head Study Suggests Significantly Greater Symptom Improvement for Symbyax(R) Compared to Lamotrigine in Bipolar Depression

May 22, 2006
Lilly Offers Tips for Disaster Preparation for Diabetes

May 19, 2006
2006 Welcome Back Awards Winners Honored for Helping Reshape the Mental Health System

May 10, 2006
Lilly to Extend Patient Assistance Programs for Medicare Patients

May 9, 2006
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Generalized Anxiety Disorder

May 4, 2006
Jury Issues Verdict in Ariad v. Lilly Patent Infringement Suit

Apr 24, 2006
Lilly Declares Second-Quarter Dividend

Apr 20, 2006
Lilly ICOS LLC Reports Results for First Quarter of 2006

Apr 20, 2006
Lilly Reports Q1 EPS of $.77, or 13% Growth

Apr 18, 2006
National Survey Emphasizes Women Need More Comprehensive Approach to Managing Depression

Apr 17, 2006
Lilly Statement on STAR

Apr 12, 2006
Lilly Announces Preliminary Coronary and Breast Cancer Results from Raloxifene Use for The Heart (RUTH) Study

Apr 6, 2006
New Data Show Cialis(R) (tadalafil) is Effective in Treating Erectile Dysfunction Caused by Traumatic Spinal Cord Injury

Apr 6, 2006
Study Examines Continued Economic Burden of Acute Coronary Syndrome Despite Standard Medical Interventions

Apr 1, 2006
CATIE Phase 2 Data Confirm Patients Stay on Treatment Longer Because of Symptom Improvement More So Than Tolerability

Mar 30, 2006
Lilly Announces Senior Leadership Changes

Mar 29, 2006
Call for Journalists to Enter the Embrace Award for Accurate, Responsible and Sensitive Reporting of Urinary Incontinence

Mar 24, 2006
Study Suggests Cymbalta(R) Significantly Reduces Core Anxiety Symptoms of Generalized Anxiety Disorder

Mar 22, 2006
Lilly Sets Date and Conference Call for First Quarter 2006 Financial Results Announcement

Mar 20, 2006
Lilly and Biosite to Collaborate on Clinical Trial Using Tailored Xigris Therapy

Mar 14, 2006
Study Shows More Potent and More Reliable Platelet Inhibition with Prasugrel Compared to Clopidogrel Even in Patients With More Reactive Platelets

Mar 9, 2006
Lilly Launches Phase III Trial of Targeted Cancer Agent

Feb 23, 2006
Lilly's Charles E. Golden Announces Retirement

Feb 21, 2006
Lilly Global Philanthropy Exceeds $500 Million in 2005

Feb 15, 2006
Eli Lilly and Company and Boehringer Ingelheim Announce Changes to Their Contractual Agreements for Yentreve(R)/AriClaim(R)

Feb 14, 2006
Study Finds Cymbalta(R) Was As Safe And Well-Tolerated As Routine Drug Treatments For Diabetic Nerve Pain

Feb 7, 2006
Lilly Launches Humalog(R) Mix50/50(TM) Insulin in United States

Feb 3, 2006
Combating Cancer with Color and Canvas: Lilly Oncology on Canvas(TM) International Art Competition Call for Entries

Jan 26, 2006
Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges

Jan 24, 2006
Women's First Pregnancy and Delivery Creates Risk for Stress Urinary Incontinence (SUI)

Jan 20, 2006
Lilly ICOS LLC Reports First Full-Year Profit in its History

Jan 18, 2006
LillyforLife(TM) Ambassador Kris Freeman Named to 2006 U.S. Olympic Ski Team

Jan 3, 2006
Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2005 Financial Results Announcement

Dec 22, 2005
Lilly to Take Asset Impairment Charges in Fourth Quarter of 2005

Dec 21, 2005
Lilly Resolves Investigation of Its Evista Marketing and Promotional Practices

Dec 20, 2005
New Study Showed No Difference in Total Treatment Costs When Comparing Those Starting Treatment with Older Conventional Antipsychotics and Those Starting Treatment with Zyprexa(R), an Atypical Antipsychotic, in the Treatment of Schizophrenia

Dec 19, 2005
Lilly Announces Dividend Increase

Dec 13, 2005
New Study Suggests Cymbalta(R) Reduced Depression Symptoms At Least As Fast As a Leading Competitor

Dec 10, 2005
Investigational Targeted Therapy May Offer Progress for Non-Hodgkin's Lymphoma Patients

Dec 9, 2005
Lilly Plans to Submit Cymbalta(R) (duloxetine hydrochloride) New Drug Application for Generalized Anxiety Disorder

Dec 9, 2005
Lilly Tells Wall Street It's Uniquely Positioned To Deliver Sustained Growth

Nov 17, 2005
Deadline Extended to Submit Nominations for Depression Awareness Award

Nov 10, 2005
National Survey Finds Weight Gain, Patient-Provider Communication and New Medical Options Critical Factors for Controlling Type 2 Diabetes

Nov 8, 2005
From the Gridiron to the State House to Cable Television: Champions in Fight Against Mental Illness to be Honored by Lilly

Nov 7, 2005
November 14 Deadline Approaching to Submit Nominations for Depression Awareness Award

Nov 2, 2005
European School of Oncology Presents 2005 ACE Reporter Awards

Oct 31, 2005
2006 Lilly Oncology on Canvas Kicks Off with a Call for Entries

Oct 20, 2005
Lilly ICOS LLC Reports First Quarterly Profit in its History

Oct 20, 2005
Lilly Reports $.73 EPS and 10 Percent Sales Growth in the Third Quarter

Oct 17, 2005
Lilly Declares Fourth-Quarter Dividend

Oct 17, 2005
J. Erik Fyrwald Elected to Lilly Board of Directors

Oct 17, 2005
Early-Phase Data Show Prasugrel Demonstrates More Consistent Platelet Inhibition Compared to Clopidogrel

Oct 13, 2005
Lilly Announces Scholarship Recipients for Those Battling Severe Mental Illness

Oct 13, 2005
Lilly Receives NCQA Certification for Its Two Latest Disease Management Programs

Oct 5, 2005
From Relationships to Working Lives: New Global Survey Reveals the True Impact and Emotional Burden of SUI Symptoms on Women

Sep 29, 2005
Lilly Announces Important Strattera(R) Label Update

Sep 28, 2005
2006 Lilly Oncology on Canvas Kicks Off with a Call for Entries

Sep 22, 2005
Lilly Sets Date and Conference Call for Third-Quarter 2005 Earnings Announcement

Sep 22, 2005
Lilly Hits One-Year Milestone of Commitment to Disclosure of Clinical Trial Results

Sep 21, 2005
World Tour of 'Lilly Oncology on Canvas' Art Exhibit Stops at D.C.'s Historic Union Station

Sep 20, 2005
Mountain Climber Reaches First Peak As Part Of Expedition To Help People Battling Depression

Sep 20, 2005
Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?

Sep 20, 2005
Lilly Announces Promotion of John C. Lechleiter to President and Chief Operating Officer

Sep 19, 2005
According to CATIE, Zyprexa(R) More Effective on Discontinuation Rate than Other Antipsychotics Studied

Sep 12, 2005
Long-Term Data on Exenatide Show Sustained Improvements in Glucose Control and Progressive Weight Reduction in People With Type 2 Diabetes

Sep 12, 2005
Pilot Study of Ruboxistaurin Showed Favorable Effects on Kidney Damage and Function in People with Type 2 Diabetes and Nephropathy

Sep 12, 2005
Phase 2 Study Shows Lilly/Alkermes Inhaled Insulin System Achieved Blood Sugar Levels Similar to Injected Insulin

Sep 12, 2005
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Insulin Glargine

Sep 6, 2005
Burden of ADHD Greater than Asthma, According to New Study

Aug 31, 2005
Lilly Provides Financial Support, Product Donations in Wake of Hurricane Katrina

Aug 31, 2005
Focus on Your Possibilities ADHD Scholarship Winners Announced

Aug 25, 2005
Journalists Recognised for Excellence in Reporting on One of the Last Medical Taboos

Aug 11, 2005
First of its Kind Urinary Incontinence Study Reveals Many Women With Stress Urinary Incontinence Symptoms Receive Off-Label Medications or None at All

Aug 8, 2005
New Study Provides In-Depth Look at How Osteoporosis Treatments Function Within Bone

Aug 2, 2005
Lilly Announces Support of Drug Industry Principles on Consumer Advertising of Prescription Medicines

Aug 2, 2005
Lilly Will Submit Ruboxistaurin Mesylate (Arxxant(TM)) to FDA for Treatment of Diabetic Retinopathy in 2005

Jul 21, 2005
Lilly ICOS' Cialis(R) (tadalafil) Reaches $1 Billion Global Sales Milestone

Jul 21, 2005
Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Cialis(R), since launch, exceed $1 billion -

Jul 21, 2005
Lilly Reports Results for Second Quarter; Sales Increase 3 Percent

Jul 6, 2005
Lilly Licenses Oral DPP-IV Inhibitor from Taisho Pharmaceutical

Jul 5, 2005
Thoracic Cancer Patients Find New Reasons for Hope with Alimta(R)

Jul 5, 2005
Treating Lung Cancer Patients Earlier May Improve Outcomes

Jun 29, 2005
Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level

Jun 24, 2005
Lilly Declares Third-Quarter Dividend

Jun 14, 2005
Phase 2 Study Shows Lilly/Alkermes Inhaled Insulin System Achieved Blood Sugar Levels Similar to Injected Insulin

Jun 12, 2005
Pilot Study of Ruboxistaurin Showed Favorable Effects on Kidney Damage and Function in People with Type 2 Diabetes and Nephropathy

Jun 11, 2005
Aggressive Diabetes Education Program Makes Positive Impact on Health of Medicaid Patients

Jun 11, 2005
New Data Show Cymbalta Improved Physical, Social and Emotional Functioning and Overall Health of Patients With Painful Diabetic Neuropathy

Jun 10, 2005
Long-Term Data on BYETTA(TM) Show Sustained Improvements in Glucose Control and Progressive Weight Reduction in People with Type 2 Diabetes

Jun 10, 2005
Study Shows BYETTA(TM) Improves Blood Sugar Levels as Effectively as Insulin Glargine

Jun 9, 2005
Lilly and Plaintiffs' Attorneys Enter Into an Agreement in Principle to Settle Majority of Zyprexa(R) Product Liability Litigation

Jun 9, 2005
Lilly Sets Date and Conference Call for Second-Quarter 2005 Earnings Announcement

Jun 9, 2005
Newly Approved First-in-Class Treatment for Type 2 Diabetes Is Now Available

Jun 8, 2005
New Scholarship Program to Help Adults Living With ADHD Focus on Their Possibilities

Jun 2, 2005
Lilly Announces Winners in Global Awards for Outstanding Achievements in Diabetes Care

May 31, 2005
Lilly Announces Senior Leadership Changes

May 31, 2005
Mountain Climber Leads Expedition of Hope for People Battling Depression

May 26, 2005
Regardless of Insurance Coverage, New Research Shows Vast Majority of People with Depression Are Not Effectively Treated

May 24, 2005
New Analysis Shows Cymbalta Reduced Anxiety Symptoms in Elderly Patients with Depression

May 24, 2005
New Analysis Highlights Gender Differences in ADHD Patients Treated with Atomoxetine

May 24, 2005
New Data Suggest Once-Daily Atomoxetine May Provide Symptom Relief for Up to 24 Hours

May 24, 2005
First Head-to-Head Study Shows Patients with Bipolar Depression Had Greater Symptom Improvement on Olanzapine and Fluoxetine HCl Capsules than Lamotrigine

May 24, 2005
National Coalition for Homeless Veterans Uniting Government and Public and Private Efforts to End Homelessness Among Veterans

May 23, 2005
New Study Showed Efficacy was Most Important Factor in Decision to Stay on Antipsychotic Treatment for Schizophrenia

May 23, 2005
Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comorbid Conditions

May 18, 2005
Non-Stimulant Strattera More Widely Available for Attention-Deficit/Hyperactivity Disorder Patients in Europe

May 18, 2005
Non-stimulant Strattera More Widely Available for Attention- Deficit/Hyperactivity Disorder in Children and Adolescents in Europe

May 17, 2005
New Data Show Gemzar(R)-Based Combination Therapies May Provide Significant Clinical Value in Early-Stage Non-Small Cell Lung Cancer

May 17, 2005
Lilly Targeted Agent Shows Promise in Treating Primary Brain Cancer

May 17, 2005
New York Psychiatrist Wins Prestigious National Mental Health Award

May 16, 2005
NAMI-San Diego President Wins National Lifetime Achievement Award

May 16, 2005
Boston-Area Author Wins Prestigious National Mental Health Award

May 16, 2005
Connecticut Latina Wins Prestigious National Mental Health Award

May 16, 2005
Oregon Mental Health Program Founder Wins National Award

May 16, 2005
Northern Arizona Woman Wins National Mental Health Award

May 16, 2005
Welcome Back Awards Honors Unsung Heroes in the Depression Community

May 16, 2005
Lilly Does Not Endorse Below-Market Offer by TRC for 0.2 Percent of Lilly's Stock

May 16, 2005
New Study Results Demonstrate Clinical Effectiveness of Gemzar(R)-Based Combination Therapy for Advanced Breast Cancer

May 16, 2005
World Tour Of 'Oncology on Canvas' Art Exhibit To Make U.S. Debut At Harrison Center For The Arts In Indianapolis

May 3, 2005
Eli Lilly and Company Opens Nominations for 9th Annual Reintegration Awards

May 2, 2005
Pain Worsens Physical and Financial Burdens for Adults with Depression Nearing Retirement, Six-Year Study Shows

Apr 29, 2005
Lilly and Amylin Announce FDA Approval of Exenatide

Apr 29, 2005
Amylin and Lilly Announce FDA Approval of BYETTA(TM) (Exenatide) Injection

Apr 18, 2005
Lilly Declares Second-Quarter Dividend

Apr 18, 2005
Lilly ICOS LLC Reports Results for First Quarter of 2005

Apr 18, 2005
Lilly Reports $.68 Earnings Per Share in the First Quarter

Apr 18, 2005
Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France

Apr 18, 2005
Lilly ICOS' Cialis(R) (tadalafil) Leads ED Market in France

Apr 14, 2005
U.S. District Court Rules in Favor of Lilly; Upholds Company's 2011 Patent on Zyprexa

Apr 13, 2005
U.S. District Court To Issue Ruling in the Zyprexa Patent Case on April 14 at 5:50 p.m. EDT

Apr 13, 2005
Eli Lilly and Company Pledges $12.5 Million to Accelerate Cancer Clinical Research

Apr 11, 2005
Unique New Study Suggests Significant Benefits of Yentreve(R) in Combination with Pelvic Floor Muscle Training for Women with Stress Urinary Incontinence

Apr 7, 2005
Spine Imaging Improves the Identification of Future Fracture Risk in Postmenopausal Women With Osteoporosis

Apr 6, 2005
Studies Show Schizophrenia Patients Taking Atypicals Stayed on Treatment Longer Than Patients Taking Older, Typical Antipsychotics

Mar 15, 2005
Lilly Sets Date and Conference Call for First-Quarter 2005 Earnings Announcement

Mar 15, 2005
Emmy Winning Actress Leads Charge to Pair People Battling Depression With Partners

Mar 9, 2005
Results of Early Data Show More Consistent Platelet Inhibition with Prasugrel Compared to Clopidogrel Across Three Distinct Trials

Mar 7, 2005
New Study Data Show Improved Cognitive Function in Elderly Patients Treated with Cymbalta for Depression

Mar 2, 2005
New BASS Sponsor Cialis(R) (tadalafil) Showcases Interactive Presence in Augusta

Feb 28, 2005
PGA TOUR Partner Cialis(R) (tadalafil) Debuts 2005 Consumer Golf Plans at The Ford Championship at Doral

Feb 10, 2005
Statement to the Media: Lilly ICOS Pleased with European Patent Office's Decision to Affirm Revocation of Pfizer's Patent on Treatment of Erectile Dysfunction

Feb 10, 2005
The Larry King Cardiac Foundation Receives $100,000 Grant from Lilly to Support 'Save a Heart a Day'

Feb 7, 2005
Lilly Announces Individual Bar Coding on All Insulin Vials

Feb 1, 2005
Lilly's Taurel Says American Health System is Unhealthy to the Core

Jan 28, 2005
Lilly Reconfirms Its Financial Guidance

Jan 28, 2005
Lilly and Boehringer Ingelheim Jointly Announce the Recision of U.S. FDA Application for Duloxetine for Treatment of Stress Urinary Incontinence

Jan 27, 2005
Eli Lilly and Company Responds to BMJ Apology and Retraction

Jan 26, 2005
Lilly ICOS LLC Reports Results for 2004

Jan 26, 2005
Lilly Delivers 10 Percent Top Line Growth for Full Year 2004

Jan 24, 2005
Cialis(R) (tadalafil) Joins BASS as Premiere Sponsor

Jan 13, 2005
Lilly Launches Public Outreach Initiative to Correct Allegations About Company and Prozac

Jan 6, 2005
Lilly Revises Conference Call Time for Fourth-Quarter and Full-Year 2004 Earnings Announcement

Jan 5, 2005
Lilly Affirms: No 'Missing' Prozac Documents and No New Scientific Information

Jan 5, 2005
Lilly Provides Financial Support and Medicines for Tsunami Relief in Southeast Asia

Jan 5, 2005
New Treatment for Depression Approved in Europe

Jan 3, 2005
Deadline Extended to Submit Nominations for Depression Awards Program

Dec 31, 2004
Lilly Issues Response to British Medical Journal

Dec 21, 2004
J. Michael Cook Elected to Lilly Board of Directors

Dec 20, 2004
Lilly Announces Dividend Increase

Dec 17, 2004
Lilly Announces Important Liver Safety Update to Strattera(R) Label

Dec 14, 2004
Study Demonstrated Long-Term Treatment with Zyprexa(R) Reduced Violent Behavior in People with Schizophrenia Compared to Risperidone

Dec 13, 2004
Lilly Sets Date and Conference Call for Fourth-Quarter and Full-Year 2004 Earnings Announcement

Dec 9, 2004
Lilly Profiles Its Exceptional New Product Flow and Pipeline to Wall Street

Dec 8, 2004
Lilly Launches Online Clinical Trial Registry at www.lillytrials.com: Company to Publish Results for All Lilly Marketed Products and Initiation of All Phase II - IV Clinical Trials

Dec 7, 2004
U.S. Winners of Oncology on Canvas International Art Competition Announced at San Antonio Breast Cancer Symposium

Dec 3, 2004
Lilly ICOS Celebrates a 'Promising' First Year of Cialis(R) (tadalafil) in the U.S.

Dec 2, 2004
Winners Announced Today at the Royal College of Art for the Oncology on Canvas International Art Competition Presented by Eli Lilly and Company

Nov 11, 2004
Eli Lilly and Company Honors U.S. Senator Gordon Smith and Others Whose Extraordinary Efforts Help People with Mental Illness Move Their Lives Forward

Nov 1, 2004
Lung Cancer Patients May Benefit From More Time Without Life-Threatening Chemotherapy Side Effects

Oct 27, 2004
Lilly Acquires Novel Compound for Insomnia from Merck KGaA

Oct 26, 2004
Awards Program Seeks Nominations Honoring Heroes of Depression Community

Oct 26, 2004
Data Indicate That Lilly's Ruboxistaurin May Have A Potentially Beneficial Effect on Diabetes-Induced Eye Disease

Oct 25, 2004
Lilly, Sankyo Announce Start of Phase 3 Clinical Trial of Antiplatelet Agent

Oct 25, 2004
Lilly Helps Thousands of Needy Hoosier Seniors with Cost of Medications

Oct 21, 2004
Lilly Announces Third-Quarter Earnings Per Share of $.69; Company Also Details Restructuring Activities

Oct 21, 2004
Lilly ICOS LLC Reports Third Quarter 2004 Cialis Worldwide Sales of $154 Million

Oct 20, 2004
New Analysis Shows Lilly ICOS' Cialis(R) (tadalafil) is Effective in Treating ED in Men with Enlarged Prostates

Oct 18, 2004
Lilly Cautions Against Effects of Drug Importation

Oct 18, 2004
Lilly Declares Fourth-Quarter Dividend

Oct 18, 2004
Cymbalta(R) Provided Sustained Pain Relief for Women with Fibromyalgia, Study Shows

Oct 14, 2004
Lilly Commends Surgeon General's Report on Bone Health

Oct 4, 2004
Analysis Showed Teriparatide Reduced Fracture Risk Independent of Bone Turnover

Oct 3, 2004
Number, Severity of Fractures, Predicts Future Risk

Sep 24, 2004
New Study Shows Women with Severe Stress Urinary Incontinence May Reconsider Surgery After Experiencing the Benefits of Yentreve(R)

Sep 22, 2004
Lilly Receives NCQA Certification for Five Disease Management Programs

Sep 22, 2004
NewsMaker Forum to Examine Barriers to Cancer Prevention Research

Sep 17, 2004
Lilly Sets Date and Conference Call for Third-Quarter 2004 Earnings Announcement

Sep 17, 2004
EU Scientific Committee Recommends Approval of Cymbalta(R) and Xeristar(R) for Treatment of Major Depressive Episodes

Sep 13, 2004
Yentreve(R), First and Only Widely Approved Pharmaceutical Option for the Treatment of Stress Urinary Incontinence Is Now Available

Sep 7, 2004
FDA Approves Antidepressant Cymbalta(R) for Treatment of Pain Caused by Diabetic Peripheral Neuropathy, Which Affects Up to 5 Million Americans

Aug 29, 2004
Lilly, Sankyo Release Phase 2 Data on Investigational Agent to Treat Certain Heart Disease Patients

Aug 26, 2004
Lilly Launches New Antidepressant Cymbalta(R)

Aug 19, 2004
Lilly ICOS' Cialis(R) (tadalafil) Shows Steady Growth in First Nine Months On the U.S. ED Treatment Market

Aug 19, 2004
FDA Approves Lilly's Alimta(R) (pemetrexed) for the Second-Line Treatment of Advanced Lung Cancer

Aug 13, 2004
Yentreve(TM)* Receives Approval Across the European Union for the Treatment of Stress Urinary Incontinence in Women

Aug 6, 2004
Lilly's Pedro Granadillo Announces Retirement

Aug 4, 2004
FDA Approves Lilly's Cymbalta(R) for the Treatment of Depression

Aug 3, 2004
Lilly to Disclose Results of All Clinical Trials for Marketed Products Via a Publicly Available Registry

Jul 29, 2004
Duloxetine Clinical Study Results Show Improvement in Stress Urinary Incontinence in Women

Jul 29, 2004
Gemzar(R) Combination Therapy Receives European Regulatory Approvals for Treatment of Ovarian Cancer

Jul 27, 2004
Alimta(R) Receives Positive Endorsement for Lung Cancer Approval from FDA Advisory Committee

Jul 22, 2004
Lilly ICOS LLC Reports Second Quarter 2004 Cialis Worldwide Sales of $137 Million

Jul 22, 2004
Lilly Delivers Sixth Consecutive Quarter of Double-Digit Sales Growth

Jul 20, 2004
NewsMaker Forum To Highlight New Advancements In Alzheimer's Care

Jul 16, 2004
New Treatment Guidelines Cite ReoPro(R) Favorably for PCI in Acute Heart Attack Patients

Jul 15, 2004
Lilly Announces Senior Leadership Changes

Jul 12, 2004
Lilly ICOS Offers 'Cialis Promise' Program to Men with ED - Pays for a Competing Product if They are Not Satisfied

Jul 8, 2004
Indiana's HoosierRx Program Partners with Eli Lilly and Company to Educate Seniors and Persons with Disabilities on Prescription Drug Discount Choices

Jun 29, 2004
Multiple Clinical Trial Analysis Shows Duloxetine Reduces Stress Urinary Incontinence Episodes and Improves Quality of Life for Women

Jun 28, 2004
Lilly Declares Third-Quarter Dividend

Jun 24, 2004
FDA Extends Action Date for Cymbalta(R) For Continued Analysis of Already-Submitted Data

Jun 24, 2004
Alimta(R) Receives CHMP Positive Opinion for Two Cancer Indications

Jun 22, 2004
Lilly's June 29 Discussion with Pharmaceutical Sell-Side Analysts Available via Webcast

Jun 17, 2004
Lilly Sets Date and Conference Call for Second-Quarter 2004 Earnings Announcement

Jun 16, 2004
New Analysis Showed Early Patient Response to FORTEO(R) in Postmenopausal Women with Osteoporosis

Jun 15, 2004
National Osteoporosis Foundation, Lilly Team Up to Raise Funds and Awareness

Jun 14, 2004
'Adequate' Treatment Isn't Enough to Make Most Depressed Patients Become Symptom Free

Jun 8, 2004
Eli Lilly and Company Opens Nominations For 8th Annual Awards for Mental Health Initiatives

Jun 8, 2004
Survey Shows Parents Likely to Modify ADHD Medication Over Summer, Despite Results Showing Treatment Helps Kids Beyond School

Jun 5, 2004
Study Data Shows Newly Approved Gemzar(R) Combination Represents Superior Treatment Outcomes in Frontline Metastatic Breast Cancer

Jun 5, 2004
Humalog(R) Mix(TM) 75/25 vs Lantus(R) in Type 2 Diabetes

Jun 5, 2004
Key Study Findings About Diabetic Microvascular Complications May Lead to Improved Screenings and Treatment for People with Diabetes

Jun 3, 2004
First Non-Stimulant ADHD Medication Available in the United Kingdom

Jun 2, 2004
Lilly Reconfirms Financial Expectations in Advance of Analyst Conferences

Jun 2, 2004
Lilly ICOS' Cialis(R) (tadalafil) Makes Impressive Strides in First Six Months on the U.S. ED Treatment Market

May 27, 2004
U.S. Ski Champion and Eli Lilly and Company Recognize Outstanding Achievements in Diabetes

May 27, 2004
'Oncology on Canvas' International Art Competition Kicks Off with a Call for Entries

May 19, 2004
Eli Lilly and Company Creates Entrepreneurial Opportunity For Formerly Homeless Veterans

May 19, 2004
FDA Grants Approval for Lilly's Gemzar(R) in Combination with Taxol(R) as First-line Treatment for Metastatic Breast Cancer

May 18, 2004
Overcoming The Confusion - Will Seniors Access The Savings From The Government's New Drug Card Program?

May 18, 2004
Lilly ICOS Announces Plans to Usher in Second Century of History and Tradition at the 2004 Cialis Western Open

May 10, 2004
Men with ED More Likely to Have High Blood Pressure

May 5, 2004
Symbyax(TM) Shown to Reduce Symptoms Associated With Suicidal Thinking in Patients With Bipolar Depression

May 5, 2004
Cymbalta(R) Helped Patients with Depression Feel Better Fast, According to Pooled Data from Two 9-week Trials

May 4, 2004
Cymbalta(R) Safely Treats Diabetic Neuropathic Pain in 52-week Study

May 4, 2004
Long-term Treatment with Zyprexa(R) Demonstrated Significant Improvement Versus Risperidone in Treating Negative Symptoms in People with Schizophrenia

May 4, 2004
Strattera Improved ADHD Impairment, Improved Family Interactions

May 3, 2004
Cymbalta(R) Helped Patients with Depression Stay Better Longer, New Data Show

May 3, 2004
Alimta(R) Showed Advances over Taxotere(R) in Second-Line Non-Small Cell Lung Cancer Study

Apr 28, 2004
Data Presented at AAN Show Improvement of Symptoms of Diabetic Peripheral Neuropathy in Patients Taking Ruboxistaurin

Apr 28, 2004
Cymbalta(R) Significantly Reduced Diabetic Neuropathic Pain in Second Placebo-controlled Study

Apr 27, 2004
The Epidemic of Overweight - New Hope on the Horizon?

Apr 27, 2004
Guidelines Include Strattera as a First-line ADHD Therapy Option

Apr 22, 2004
New Data Show Behavioral Education Program Helps Patients Treated with Antipsychotic Medications Reduce Weight and Improve Overall Wellness

Apr 20, 2004
Boeing Taps InnoCentive to Bring R&D Challenges to Top Scientific Minds Worldwide

Apr 19, 2004
Lilly Declares Second-Quarter Dividend

Apr 19, 2004
Lilly ICOS LLC Reports First Quarter 2004 Global Cialis Sales of $108 million

Apr 19, 2004
Lilly Delivers Strong Double-Digit Sales Growth for the Fifth Consecutive Quarter

Apr 14, 2004
Defending Champion Tiger Woods Heads Field in 101st Western Open

Apr 6, 2004
Lilly Endows Two Chairs at the Oklahoma Medical Research Foundation with $6 Million Gift

Mar 30, 2004
FDA Approves Injectable Form of Lilly's Zyprexa(R)

Mar 25, 2004
U.S. Attorney's Office in Pennsylvania Investigating Lilly's Marketing Practices

Mar 24, 2004
Progress of Lilly MDR-TB Partnership Highlighted as Part of World TB Day

Mar 23, 2004
Lilly ICOS Enjoys Early Success For Cialis(R) in ED Marketplace, Surpasses Levitra(R) in New U.S. Prescriptions

Mar 22, 2004
New Data Offer Sobering Insights Into the Significance of Drug-Resistant Tuberculosis

Mar 12, 2004
Lilly Sets Date and Conference Call for First-Quarter 2004 Earnings Announcement

Mar 11, 2004
New PGA TOUR Partner Cialis(R) (tadalafil) Debuts Consumer Golf Plans at The Honda Classic

Mar 10, 2004
Lilly Launches Monthly NewsMaker Forum

Mar 2, 2004
Lilly's Taurel Foreshadows Unprecedented Age Wave Breaking Over American Society

Feb 18, 2004
Lilly Collaborates to Create Center of Excellence in Protein Sciences for Indiana

Feb 12, 2004
Lilly Completes Acquisition of Applied Molecular Evolution

Feb 11, 2004
Three Head-to-Head Studies Demonstrate That Zyprexa Delays Relapse in Patients with Schizophrenia Significantly Longer Than Other Competitors in Its Class

Feb 9, 2004
InnoCentive Expands Scientific Network Into Korea

Feb 9, 2004
Large-Scale Study in the British Journal of Urology Shows More Than One Out of Three Women With Urinary Incontinence Suffer From Stress Urinary Incontinence

Feb 5, 2004
FDA Approves Alimta(R)-Cisplatin Combination For Treatment of Asbestos-Related Cancer

Feb 5, 2004
Lilly Unveils Enhanced Effort to Combat Counterfeit Drugs

Feb 2, 2004
Injectable Zyprexa(R) Now Available in First Markets

Jan 29, 2004
Lilly ICOS LLC Reports Results for 2003

Jan 29, 2004
Lilly Delivers Outstanding Sales Growth of 17 Percent in the Fourth Quarter

Jan 27, 2004
Lilly Expresses Concerns With Opinion of ADA Panel On Antipsychotic Drugs and Obesity and Diabetes

Jan 26, 2004
New Cialis(R) Ad to Debut During Super Bowl XXXVIII

Jan 23, 2004
Western Golf Association Announces Cialis(R) As New Title Sponsor of the 2004 Cialis Western Open

Jan 21, 2004
Lilly Unveils Participation in Medicare Prescription Drug Discount Card

Jan 14, 2004
FDA Approves Zyprexa(R) for Maintenance of Bipolar Disorder

Jan 12, 2004
Lilly Launches Third Venture Capital Fund

Jan 7, 2004
InnoCentive Gives Researchers and Scientists Access to the eBay Marketplace

Jan 7, 2004
Lilly Sets Date and Conference Call for Fourth-Quarter and Full-Year 2003 Earnings Announcement

Jan 6, 2004
InnoCentive Sponsors the 91st Indian Science Congress

Jan 5, 2004
Lilly Announces 2004 Financial Guidance